Related Experiment Videos

Comparative effects of phenobarbital, DDT, and lindane on mouse hepatocyte gap junctional intercellular communication

J E Klaunig1, R J Ruch, C M Weghorst

  • 1Department of Pathology, Medical College of Ohio, Toledo 43614.

Insights

Tumor promoters like phenobarbital, DDT, and lindane inhibit cell communication. While DDT and lindane cause lasting effects, cells become resistant to phenobarbital over time.

Area of Science:

  • Cell biology
  • Toxicology
  • Biochemistry

Background:

  • Gap junctional intercellular communication (GJIC) is crucial for tissue homeostasis and growth control.
  • Tumor promoters are known to disrupt GJIC, but the underlying mechanisms are unclear.

Purpose of the Study:

  • To compare the kinetics of GJIC inhibition by three hepatic tumor promoters: phenobarbital, DDT, and lindane.
  • To investigate the reversibility and long-term effects of these promoters on GJIC.
  • To explore potential mechanisms, including cytochrome P450 and cAMP pathways.

Main Methods:

  • Primary mouse hepatocytes were cultured and treated with phenobarbital, DDT, and lindane.
  • Dye coupling assays were used to measure GJIC inhibition.
  • Experiments involved varying exposure times, doses, and the use of enzyme inhibitors (SKF-525A) and cAMP analogs (8-bromo-cAMP).

Main Results:

  • All three promoters inhibited GJIC in a time- and dose-dependent manner.
  • GJIC recovered within 0.5-1.5 hours after promoter removal.
  • Prolonged exposure led to refractoriness to phenobarbital but not to DDT or lindane.
  • SKF-525A blocked phenobarbital's effect but not DDT's or lindane's, while 8-bromo-cAMP prevented inhibition by all three.

Conclusions:

  • Tumor promoters exhibit distinct kinetics and mechanisms in inhibiting GJIC.
  • Phenobarbital's effect appears mediated by cytochrome P450, while DDT and lindane's mechanisms differ.
  • The cAMP pathway is involved in preventing promoter-induced GJIC inhibition by all tested compounds.

Related Concept Videos